Fast-Diag

Fast-Diag is a company focused on the diagnostics and treatment opportunities based on Alpha-fetoprotein (AFP) and its receptor. It offers CA-62, an AFP receptor measurement in biological fluids to detect a tumor. The company is also engaged in the development of OncoShuttle, a drug delivery system based on native AFP, which can bring agents inside the tumor cell via receptor-mediated endocytosis.